chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker (medical assistant) and refers to a patient of unkown age and gender. Information about the patient's relevant medical history and concomitant medications was not reported. On 17-AUG-2015, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # K020181, expiration date 24-JUN-2016, exact dose was not reported) route of administration defaulted to oral. No adverse effects reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been information.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker (medical assistant) and refers to a patient of unknown age and gender. Information about the patient's relevant medical history and concomitant medications were not reported. On 13-AUG-2015, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # K020181, expiration date 24-JUN-2016, exact dose was not reported) route of administration defaulted to oral. No adverse effects reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Joint effusion
Clinical narrative: This spontaneous report was received from a healthcare worker and refers to a 67 year old female patient who was allergic to penicillin, cephalosporins and iodine. She did not have any pertinent medical history. On 11-SEP-2015, the patient was vaccinated with PNEUNOVAX23 injection, 0.5 ml, intramuscularly, lot # I003188, expiration date 06-JUL-2016. The patient's concomitant therapies included unspecified blood pressure medications, unspecified cholesterol medications, unspecified inhalers and unspecified "supplements". On 12-SEP-2015 (also reported as "next day after receiving PNEUMOVAX23)"), the patient developed redness, swelling and "hot" at the injection site as well as fluid around the elbow. She sought medical attention and was seen by an unspecified physician on an unspecified date. On an unspecified dates, she was given BENADRYL and MEDROL dose pack as a treatment for the events. No lab diagnostic studies were performed. Outcomes of the events were not reported. Relatedness between the events and PNEUNOVAX23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 46.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Injection site warmth, Joint effusion
Clinical narrative: This spontaneous report was received from a healthcare worker and refers to a 46 year old female patient with sulfa and cefprozil allergy. She did not have any pertinent medical history. On 26-AUG-2015, the patient was vaccinated with PNEUMOVAX 23 injection, 0.5 ml, intramuscularly, lot # L003188, expiration date 06-JUL-2016. The patient's concomitant therapies included unspecified thyroid medication and unspecified "supplements". On 27-AUG-2015 (also reported as "next day after receiving PNEUMOVAX 23", the patient developed redness, swelling and "hot" at the injection site as well a fluid around the elbow. She sought medical attention and was seen by an unspecified physician on an unspecified date. The patient was not given any treatment for the events. No lab diagnostic studies were performed. Approximately on 02-SEP-2015 (reported as "about a week after receiving PNEUMOVAX 23)", she recovered from the events. Relatedness between the events and PNEUMOVAX 23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV9
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On unspecified dates (either 17-SEP-2015 or 18-SEP-2015) the patients wre vaccinated with improperly stored GARDASIL 9 (lot # L011846, expiration date 16-JUN-2017; Lot # L014415, expiration date 25-JUL-2016; Lot # L013429, expiration date 21-JUL-2017) (dose and route of administration were not reported). No adverse effects or product quality complaint were reported. This is one of the three cases reported by the same source. Additional informtaion has been requested.
Age: 17.0
Sex: F
Vaccine: HPV9, MNQ
Symptoms: Injection site mass
Clinical narrative: This spontaneous report was received from a nurse practitioner (N.P.) concerning a 17 year old female patient. The patient had no pertinent concurrent conditions, medical history or drug reactions. On 20-AUG-2015, the patient was vaccinated with the first dose of GARDASIL 9 as well as a dose of MENACTRA both in the left deltoid (dose, Lot No. and route of administration were not reported). Concomitant medications included unspecified topical acne medication. The patient called the office and complained of a "grade size mass" in the left deltoid which appear in approximately 2015 on an unknown day. No laboratory diagnostics were conducted. The patient would visit the office on 15-SEP-2015, reported as "today" for an assessment. The outcome of injection site mass was unknown. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse via company representative refers to a patient of unknown age and gender. No pertinent medical history was reported. On 23-SEP-2015, the patient was vaccinated with expired dose of ZOSTAVAX VIAL (lot # K008882 and expiration date 20-SEP-2015). No adverse effects were reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare professional refers to two unspecified patients of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patients were vaccinated with improperly stored VARIVAX injection, lot # L020004, expiry date: 02-JUN-2017, lot # L006384, expiry date: 25-FEB-2017 or lot # L01912, expiry date: 27-MAY-2017 (strength, dose and route unspecified). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 22-SEP-2015, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 injection (lot# K004483, expiry date 16-AUG-2015; dose and route of administration were not reported). There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
Age: 67.0
Sex: M
Vaccine: PPV
Symptoms: Full blood count, Injection site erythema, Injection site swelling, Injection site warmth, Joint effusion
Clinical narrative: This spontaneous report was received from a healthcare worker and refers to a 67 year old male patient. He did not have any pertinent medical history, drug reactions or allergies. On 26-AUG-2015, the patient was vaccinated with PNEUMOVAX 23 injection, 0.5 ml, intramuscularly, lot # I003188, expiration date 06-JUL-2016 for prevention against pneumonia. The patient's concomitant therapies included unspecified cholesterol medication. On 27-AUG-2015 (also reported as "next day after receiving PNEUMOVAX 23"), the patient developed redness, swelling and "hot" at the injection site as well as fluid around the elbow. He sought medical attention and was seen by an unspecified physician on an unspecified date. On an unspecified date, the patient was give prednisolone (manufacturer unknown) as a treatment for the events. On an unspecified date after receiving PNEUMOVAX 23, a complete blood count, comprehensive metabolic panel and lipid panel were carried out (no results were provided). At the time of the report, the patient was recovering from the events. Relatedness between the events and PNEUMOVAX 23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 67.0
Sex: M
Vaccine: PPV
Symptoms: Lipids, Metabolic function test
Clinical narrative: This spontaneous report was received from a healthcare worker and refers to a 67 year old male patient. He did not have any pertinent medical history, drug reactions or allergies. On 26-AUG-2015, the patient was vaccinated with PNEUMOVAX 23 injection, 0.5 ml, intramuscularly, lot # I003188, expiration date 06-JUL-2016 for prevention against pneumonia. The patient's concomitant therapies included unspecified cholesterol medication. On 27-AUG-2015 (also reported as "next day after receiving PNEUMOVAX 23"), the patient developed redness, swelling and "hot" at the injection site as well as fluid around the elbow. He sought medical attention and was seen by an unspecified physician on an unspecified date. On an unspecified date, the patient was give prednisolone (manufacturer unknown) as a treatment for the events. On an unspecified date after receiving PNEUMOVAX 23, a complete blood count, comprehensive metabolic panel and lipid panel were carried out (no results were provided). At the time of the report, the patient was recovering from the events. Relatedness between the events and PNEUMOVAX 23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On unspecified dates (either 17-SEP-2015 or 18-SEP-2015), the patiens were vaccinated with improperly stored PNEUMOVAX (lot # K022886, expiration date: 09-JUN-2016)(dose and route of administration were not reported). No adverse effects or product quality complaint were reported. This is one of the three cases reported by the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage
Clinical narrative: This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored (at the temperature of 34-35- unit unknown) unspecified doses of MMR II lot # K011317, expiry date: 13-AUG-2016, therapy type: rHA or lot# K014833, expiry date: 14-SEP-2016, therapy type: rHA (dose, site and route of administration were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HEPA, HPV9
Symptoms: Injection site mass
Clinical narrative: This spontaneous report was received from a nurse practitioner (N.P.) concerning a 15 year old female patient. The patient had no pertinent concurrent conditions, medical history or drug reactions. On 21-JUN-2015, the patient was vaccinated with the first dose of GARDASIL 9 intramuscular as well as a dose of VAQTA, both in the left deltoid (dose and Lot No. were not reported). On 10-AUG-2015, the patient came back to the office complaining of a mass at the injection site of the VAQTA and GARDASIL 9. The nurse described the mass as grape in size in the upper deltoid and deeper than subcutaneous tissue. The patient was directed to see a surgeon, who stated that this was a vaccine related reaction and patient was prescribed an unspecified antibiotic as treatment. The reporter does not know if this patient has had resolution yet, because she has not heard nothing from the surgeon nor the patient. No laboratories studies were performed. No Product Quality Complaint (PQC) was involved. The outcome of vaccination site reaction was unknown. The reporter considered vaccination site reaction to be related to GARDASIL 9 and VAQTA. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a physician refers to an unspecified number of patients of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. The physician reported that on an unknown date, if the GARDASIL series had been interrupted, he had restarted the GARDASIL series, (Lot #, exp. date, strength, dose and frequency were not reported) for the unspecified patients. No adverse effects were reported. Additional information is not expected as the reporter did not want to be contacted.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to a 4 year old patient of unknown gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 22-JUL-2015, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # K016129, exp. date: 23-SEP-2016) (dose, strength, route and frequency were not reported). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaint (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to a 4 year old patient of unknown gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 29-JUL-2015, the patient was vaccinated with improperly stored VARIVAX (lot # K016129, exp. date: 23-SEP-2016) (dose, strength, route and frequency were not reported). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients of unknown age and gender. Between 09 to 23-SEP-2015, the patients received unspecified dose in (Oka/Merck) VARIVAX immunization series that were improperly stored (dose and route were not reported). The nurse provided potential lot information for doses administered: Lot # L017142 with exp. date on 13-MAY-2017; K015994 with exp. date on 23-SEP-2016 and L019130 with exp. date on 27-MAY-2017. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to a 4 year old patient of unknown gender. No concurrent medication, medical history or allergy/drug reactions were reported. On 22-JUL-2015, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # K016129, exp date: 25-SEP-2016) (dose, strength, route and frequency were not reported). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. No pertinent medical history was reported. On 22-SEP-2015, the patient was vaccinated with improperly stored ROTATEQ (lot # K016261 and expiration date 23-JUN-2016 or K007912 and expiration date 30-MAR-2016. No adverse effects reported. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: This spontaneous report was received from a physician refers to a patient of unknown age and gender. Patient's medical history, concurrent conditions and drug reactions/allergies were not reported. Reporting physician stated that the patient may have received vaccination with unspecified doses of M-M-R II on unspecified dates. No concomitant medications were reported. On an unknown date in March 2003, the patient's M-M-R II titers were drawn which came back as negative for rubeola. Reporting physician also stated that the patient received one dose of M-M-R II on 07-FEB-2005 due to negative rubeola titer. Outcome of the event was unknown. Physician did not assessed the causality of the event with respect to vaccination with M-M-R II. Additional information is not expected as the reporter did not wish further contact.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant referring to multiple unspecified patients of unknown age and gender. Concurrent conditions, pertinent medical history or concomitant therapies were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of VAQTA (lot # J005061, expiration date: 22-OCT-2015) (dose, frequency and route of administration were not reported). No adverse effects were reported. No PQC was involved. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse refers to an unspecified number of patients of unknown age and gender. Between 09 to 23-SEP-2015, the patients received unspecified doses (Merck) PROQUAD that were improperly stored (doses and route were not provided). The nurse provided potential lot information for doses administered: L023113 with exp. date on 24-DEC-2016 and L023114 with exp. date on 24-DEC-2016. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Licensed Vocational Nurse regarding unspecified patients of unknown demographics. There was no information about pertinent medical history, drug reactions or drug allergies. On 24-AUG-2015, the patient was vaccinated with 8 doses of improperly stored (Merck) PROQUAD lot # L005297 and expiry date: 17-AUG-2016. No adverse effect was reported. The outcome of the event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Licensed Vocational Nurse regarding unspecified patients of unknown demographics. There was no information about pertinent medical history, drug reactions or drug allergies. On 24-AUG-2015, the patients were vaccinated with 6 doses improperly stored (Oka/Merck) VARIVAX lot # L005299 and expiry date: 17-FEB-2017. No adverse effect was reported. The outcome of the event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 29.0
Sex: F
Vaccine: DTAP
Symptoms: Drug administered to patient of inappropriate age, Erythema, Exposure during pregnancy, Pain, Wrong drug administered
Clinical narrative: This prospective pregnancy case was reported by a physician via call center representative and described the occurrence of erythema in a 29-year-old female patient who received INFANRIX (batch number H7S99, expiry date 17th MAY 2017). Concomitant products included prenatal vitamins. On 21st AUGUST 2015, the patient received the 1st dose of INFANRIX (intramuscular). The patient's last menstrual period was on 22nd DECMBER 2014 and estimated date of delivery was 28th SEPTEMBER 2015. The patient received INFANRIX at week 34 of the pregnancy and during the third trimester of pregnancy. On 21st AUGUST 2015, an unknown time after receiving INFANRIX, the patient experienced wrong vaccine administered and inappropriate age of vaccine administration. On an unknown date, the patient experienced erythema, pain and vaccine expose during pregnancy. On an unknown date, the outcome of the erythema, pain, wrong vaccine administered, inappropriate age of vaccine administration and vaccine exposure during pregnancy were unknown. The pregnancy was ongoing. It was unknown if the reporter considered the erythema and pain to be related to INFANRIX. Additional details provided were as follows: The case was not previously reported to anyone. On 21st AUGUST 2015, a pregnant patient received 1st dose of INFANRIX instead of Tdap vaccine, which led to wrong vaccine administered and an inappropriate age at vaccination. On an unknown date, less than a month after receiving 1st dose INFANRIX vaccine, the patient experienced redness and soreness (pain).
Age: 23.0
Sex: M
Vaccine: HEP
Symptoms: Paraesthesia
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of tingling sensation in a 23-year-old male patient who received ENGERIX B adult (batch number 92M2J, expiry date 3rd FEBRUARY 2017). On 17th SEPTEMBER 2015 08:45, the patient received the 1st dose of ENGERIX B adult 20 pg. On 18th SEPTEMBER 2015, 1 days after receiving ENGERIX B adult, the patient experienced tingling sensation. On an unknown date, the outcome of the tingling sensation was unknown. It was unknown if the reporter considered the tingling sensation to be related to ENGERIX B adult Additional details were received as follows: The patient experienced a sensation of little needles (tingling sensation) that came and went from his torso to his neck on both the sides.
Sex: U
Vaccine: RV5
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant, refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. The medical assistant informed that on 22-SEP-2015, the patient was vaccinated with a expired dose of ROTATEQ oral, lot # J011340, expiration date 14-MAY-2015. Concomitant therapy was not reported. There was not adverse events. Additional information has been requested.
Age: 19.0
Sex: U
Vaccine: HEPA
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse, refers to a 19 year old patient of unknown gender Information about the patient's medical history and concurrent conditions was not provided. On 21-SEP-2015, the patient was vaccinated with an expired dose of VAQTA lot # J009441, expiration date 23-AUG-2015, (administration route was not provided). No concomitant therapies were reported. No adverse experienced were reported. Additional information has been requested.
Sex: F
Vaccine: HPV9
Symptoms: Pyrexia
Clinical narrative: This spontaneous report as received from a Licensed Practical Nurse via field employee refers to a female patient of unknown age. ON 21-SEP-2015 the patient was vaccinated with GARDASIL 9 dose 1. On 22-SEP-2015, the patient experienced fever, 102F, after receiving the first dose of GARDASIL 9. Patient sought medical attention by calling physician's office. The outcome of the event was unknown. No product quality complaint was involved. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Rash, Vasculitis
Clinical narrative: This spontaneous report has been received from a 62 year old female patient, who was reporting on herself. The patient's pertinent medical history was not reported. The patient's concurrent condition included borderline high blood pressure. The patient had no allergies to medications. In April 2015, the patient was vaccinated with an unknown dose of ZOSTAVAX (route, lot# and expiry date were not reported. Concomitant therapies included levothyroxine sodium (manufacturer unknown) and amlodipine. In June 2015, the patient experienced rash that hurt and itched, under her bra line of the left breast. The rash spread to her trunk, legs, hands and face and, on an unknown date in 2015, she was diagnosed with vasculitis. The rash was not diagnosed as shingles. She was also advised that "something triggered her immune system". She was taken off her regular medications (levothyroxine sodium (manufacturer unknown) and amlodipine) and given 50 mg of cortisone and 25 mg of prednisone (manufacturer unknown) daily. At the time of report, the patient was till under treatment with 5 mg of prednisone (manufacturer unknown). She reported that "nothing but that" could relieve the pain and itch. The outcome of the events was not reported. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blood pressure increased, Immune system disorder, Rash, Rash pruritic, Vasculitis
Clinical narrative: This spontaneous report has been received from a 62 year old female patient, who was reporting on herself. The patient's pertinent medical history was not reported. The patient's concurrent condition included borderline high blood pressure. The patient had no allergies to medications. In April 2015, the patient was vaccinated with an unknown dose of ZOSTAVAX (route, lot# and expiry date were not reported. Concomitant therapies included levothyroxine sodium (manufacturer unknown) and amlodipine. In June 2015, the patient experienced rash that hurt and itched, under her bra line of the left breast. The rash spread to her trunk, legs, hands and face and, on an unknown date in 2015, she was diagnosed with vasculitis. The rash was not diagnosed as shingles. She was also advised that "something triggered her immune system". She was taken off her regular medications (levothyroxine sodium (manufacturer unknown) and amlodipine) and given 50 mg of cortisone and 25 mg of prednisone (manufacturer unknown) daily. At the time of report, the patient was till under treatment with 5 mg of prednisone (manufacturer unknown). She reported that "nothing but that" could relieve the pain and itch. The outcome of the events was not reported. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: FLUX
Symptoms: Headache
Clinical narrative: Headache.
Age: 2.0
Sex: M
Vaccine: UNK
Symptoms: Blood test, Computerised tomogram, Headache, Lethargy, Lumbar puncture
Clinical narrative: Stiff neck, headache and lethargic initially, at 2:00 AM on 09/25/2015, developed fever 100.2. Brought to Emergency room at 11:30 AM on 09/25/2015 per Dr's instruction. Cat Scan, blood work, x-rays and spinal tap performed. Released at 4:45 PM on 09/25/2015. At 5:00 AM on 09/26/2015 had temperature of 100.7. Still stiff and lethargic. Treatment recommended by Doctor, warm compress on neck and children's Ibuprofen for fever and pain.
Age: 2.0
Sex: M
Vaccine: UNK
Symptoms: Musculoskeletal stiffness, Pyrexia, X-ray
Clinical narrative: Stiff neck, headache and lethargic initially, at 2:00 AM on 09/25/2015, developed fever 100.2. Brought to Emergency room at 11:30 AM on 09/25/2015 per Dr's instruction. Cat Scan, blood work, x-rays and spinal tap performed. Released at 4:45 PM on 09/25/2015. At 5:00 AM on 09/26/2015 had temperature of 100.7. Still stiff and lethargic. Treatment recommended by Doctor, warm compress on neck and children's Ibuprofen for fever and pain.
Age: 12.0
Sex: M
Vaccine: HPV4
Symptoms: Blindness, Dizziness, Tinnitus
Clinical narrative: At first light headed, then loss of vision, ringing in ears, ready to faint.
Age: 57.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Hyperhidrosis, Injection site reaction, Pain, Poor quality sleep
Clinical narrative: Patient began having moderate to severe pain and injection site and became diaphoretic alternating with episodes of chills.  He did not sleep well at all and the morning of 9/25/15 he had a syncopal event resulting in hospitalization.
Age: 57.0
Sex: M
Vaccine: PPV
Symptoms: Syncope
Clinical narrative: Patient began having moderate to severe pain and injection site and became diaphoretic alternating with episodes of chills.  He did not sleep well at all and the morning of 9/25/15 he had a syncopal event resulting in hospitalization.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Induration, Rash, Skin warm, Tenderness
Clinical narrative: Hard bumpy rash, painful to the tough and hot.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site haemorrhage, Injection site swelling, Mobility decreased, Pain in extremity, Sensory loss
Clinical narrative: At the time of vaccination, the area of injection started to bleed and because swollen. Later that evening the patient said that the swelling went down but that she lost feeling in her right arm. When she came to see me the following day, the site of injection was normal with no signs of a reaction (all swelling was gone) but patient said that she could barely move her arm and that it was very sore.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, FLUX, HIBV, PNC13, RV1
Symptoms: Dysphonia, Injection site swelling, Injection site urticaria, Pyrexia
Clinical narrative: Low-grade fever: 99.9. Substantial swelling of thigh on left leg, larger than the vaccine admin site. HIVES at vaccine admin site, hives spread over next few days, call doctor on Saturday to ask if can give Benadryl. Hives last a total of 6 days, they respond to the Benadryl, first by just reducing back to only covering the area at the vaccine sites on the thighs, then becoming smaller, then just disappearing. Hoarsness of voice begins at same time, Hoarseness lasts 2 weeks post vaccine admin. Please note: As same vaccines are usually administered at 4 month visit per recommended vaccine administration schedule, spoke with pediatrician about spacing out recommended vaccines e.g. instead of having all 8 vaccines administered at once again... doing one vaccine (or combo vaccine) a week in an attempt to a. identify the one that caused the allergy and/or b. reduce the chance of a repeated allergy by introducing less vaccines at once. Fingers crossed this works to address the problem and we see no further reactions/illness.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Pain in extremity, Radiculitis brachial
Clinical narrative: Brachial Neuritis. Pain in vaccinated arm, joint pain in vaccinated arm.
Age: 31.0
Sex: F
Vaccine: DTAP, PPV
Symptoms: Bedridden, Chills, Cough, Dysphonia, Headache
Clinical narrative: Hoarseness and coughing. Later that evening, high fever, chills, swollen and red injection site, severe headache, nausea, bed-ridden for a couple days.
Age: 31.0
Sex: F
Vaccine: DTAP, PPV
Symptoms: Injection site erythema, Injection site swelling, Nausea, Pyrexia
Clinical narrative: Hoarseness and coughing. Later that evening, high fever, chills, swollen and red injection site, severe headache, nausea, bed-ridden for a couple days.
Age: 1.0
Sex: M
Vaccine: FLUX, HEPA, HIBV, MMR, PPV, VARCEL
Symptoms: Pyrexia, Rash, Rash erythematous
Clinical narrative: 101 Fever, red spots on belly.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia
Clinical narrative: High fever.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Injection site pain, Injection site reaction, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Pain and stiffness at injection site that radiated down arm and into chest. Red Blotchy areas on skin on left arm. Patient states started day of administration and then area affected continued to spread for the next few days. Now it is 2 weeks later and patient is still experiencing stiffness, and pain, and still some blotchy redness on sking of left arm.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Rash macular
Clinical narrative: Pain and stiffness at injection site that radiated down arm and into chest. Red Blotchy areas on skin on left arm. Patient states started day of administration and then area affected continued to spread for the next few days. Now it is 2 weeks later and patient is still experiencing stiffness, and pain, and still some blotchy redness on sking of left arm.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site swelling, Injection site warmth, Pain
Clinical narrative: PATIENT REPORTED SWELLING AT INJECTION SITE, SLIGHT WARMTH, AND SORENESS IN TRYING TO RAISE ARM ABOVE HEAD.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site reaction, Rash vesicular
Clinical narrative: Developed red, blistered rash on arm below injection site. Was advised to take Zyrtec. Two follow up calls were made to pt over the following week. At time of first call she reported improvement of rash and at second follow call reported resolution.
Age: 53.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Chills, Decreased appetite, Injection site erythema, Injection site pain, Nausea
Clinical narrative: Patient had nausea, chills, loss of appetite. She also had pain and redness on the entire surface of left upper arm where she received Pneumovax 23 and Fluzone Quad injections.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chills, Fatigue, Hyperhidrosis, Pain
Clinical narrative: Body aches, vomiting, weakness, fatigue, sweats and chills.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Body aches, vomiting, weakness, fatigue, sweats and chills.
Age: 68.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Blood pressure decreased, Dizziness, Heart rate decreased, Immediate post-injection reaction
Clinical narrative: Patient received Fluzone HD in the right arm. She received Prevnar 13 in the left arm following the first vaccine. Immediately following administration, she announced she became light headed. She held her hed between her legs at that time. Her blood pressure and pulse dropped and she was sweating. Paramedics were called to the scene.
Age: 60.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Pain
Clinical narrative: Patient had swelling in her rt arm where vaccine was administered and she could not raise her arm without being in a lot of pain.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Hyperhidrosis, Syncope
Clinical narrative: The patient fainted briefly for few seconds upon administering the flu vaccine.  Pulse and breathing within normal limits, patient sweat a little.  Patient was coherent and conscious, EMS was called just in case, but not use service due to non life threatening.
Age: 56.0
Sex: M
Vaccine: PPV
Symptoms: Burning sensation, Mobility decreased, Pain in extremity
Clinical narrative: Patient reported a burning sensation at time of administration, then reported soreness of her arm. Patient reported that arm from elbow to shoulder was sore, and that she could not lift that arm. Soreness persisted for 3 days before patient sought medical attention.
Age: 1.26
Sex: M
Vaccine: DTAP, PNC13
Symptoms: Blood test normal, Computerised tomogram normal, Eye movement disorder, Nuclear magnetic resonance imaging normal, Strabismus
Clinical narrative: 9/21/2015- left eye was slightly crossed. 9/22/2015 left eye straightened out, right eye started crossing. 9/23 - right eye completely crossed. 9/24 - loss of some movement in right eye, he couldnt turn his eye well. 9/25 - vision impairment in right eye, loss of most movement in right eye.
Age: 1.26
Sex: M
Vaccine: DTAP, PNC13
Symptoms: Visual impairment
Clinical narrative: 9/21/2015- left eye was slightly crossed. 9/22/2015 left eye straightened out, right eye started crossing. 9/23 - right eye completely crossed. 9/24 - loss of some movement in right eye, he couldnt turn his eye well. 9/25 - vision impairment in right eye, loss of most movement in right eye.
Age: 1.26
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR
Symptoms: Abnormal behaviour, Autism, Blood aluminium increased, Blood heavy metal test, Decreased eye contact
Clinical narrative: This was the first time I had ever seen one of my children turn completely yellow. (I have had three sons prior to this who were at this time 20, 15 and 10 years old.) I was so freaked out I brought him back to the doctor who told me it must be something I was eating and that it couldn't have been his vaccines.  I told him what a difficult time my boy was having, the screaming, the lack of sleep--he told me to stop nursing him and give him Formula.  I did not.  I continued to nurse him and he regained his normal color after several months.  His second very bad reaction, which we believed changed his whole personality, was on to his vaccinations came when he got his MMR ON 12/3/2010.  Patient had an extremely high fever that night, (106), which we brought down with advised Tylenol and Motrin alternated every four hours and wet cloths to cool him down.  He shook like seizures, screamed, started pooping his pants with watery poop that ended up last five years to date.  He started waving his hands, refusing to wear shoes or clothes, screamed and hit himself, could not look at me anymore and kept spinning in circles and banging his head.  He also started repeating odd things he would hear and lined up all kinds of bizzare objects.  He was not the same little boy anymore.  We knew he was seriously damaged since the day he took that shot.  We subsequently brought him back to his doctor to tell him what had happened to Patient.  He, Dr. said he suspected autism and sent us to a specialist.
Age: 1.26
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR
Symptoms: Diarrhoea, Dyskinesia, Hair metal test abnormal, Head banging, Insomnia
Clinical narrative: This was the first time I had ever seen one of my children turn completely yellow. (I have had three sons prior to this who were at this time 20, 15 and 10 years old.) I was so freaked out I brought him back to the doctor who told me it must be something I was eating and that it couldn't have been his vaccines.  I told him what a difficult time my boy was having, the screaming, the lack of sleep--he told me to stop nursing him and give him Formula.  I did not.  I continued to nurse him and he regained his normal color after several months.  His second very bad reaction, which we believed changed his whole personality, was on to his vaccinations came when he got his MMR ON 12/3/2010.  Patient had an extremely high fever that night, (106), which we brought down with advised Tylenol and Motrin alternated every four hours and wet cloths to cool him down.  He shook like seizures, screamed, started pooping his pants with watery poop that ended up last five years to date.  He started waving his hands, refusing to wear shoes or clothes, screamed and hit himself, could not look at me anymore and kept spinning in circles and banging his head.  He also started repeating odd things he would hear and lined up all kinds of bizzare objects.  He was not the same little boy anymore.  We knew he was seriously damaged since the day he took that shot.  We subsequently brought him back to his doctor to tell him what had happened to Patient.  He, Dr. said he suspected autism and sent us to a specialist.
Age: 1.26
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR
Symptoms: Metal poisoning, Personality change, Pyrexia, Screaming, Seizure like phenomena
Clinical narrative: This was the first time I had ever seen one of my children turn completely yellow. (I have had three sons prior to this who were at this time 20, 15 and 10 years old.) I was so freaked out I brought him back to the doctor who told me it must be something I was eating and that it couldn't have been his vaccines.  I told him what a difficult time my boy was having, the screaming, the lack of sleep--he told me to stop nursing him and give him Formula.  I did not.  I continued to nurse him and he regained his normal color after several months.  His second very bad reaction, which we believed changed his whole personality, was on to his vaccinations came when he got his MMR ON 12/3/2010.  Patient had an extremely high fever that night, (106), which we brought down with advised Tylenol and Motrin alternated every four hours and wet cloths to cool him down.  He shook like seizures, screamed, started pooping his pants with watery poop that ended up last five years to date.  He started waving his hands, refusing to wear shoes or clothes, screamed and hit himself, could not look at me anymore and kept spinning in circles and banging his head.  He also started repeating odd things he would hear and lined up all kinds of bizzare objects.  He was not the same little boy anymore.  We knew he was seriously damaged since the day he took that shot.  We subsequently brought him back to his doctor to tell him what had happened to Patient.  He, Dr. said he suspected autism and sent us to a specialist.
Age: 1.26
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR
Symptoms: Self injurious behaviour, Speech disorder, Stool heavy metal positive, Tremor, Urine aluminium increased
Clinical narrative: This was the first time I had ever seen one of my children turn completely yellow. (I have had three sons prior to this who were at this time 20, 15 and 10 years old.) I was so freaked out I brought him back to the doctor who told me it must be something I was eating and that it couldn't have been his vaccines.  I told him what a difficult time my boy was having, the screaming, the lack of sleep--he told me to stop nursing him and give him Formula.  I did not.  I continued to nurse him and he regained his normal color after several months.  His second very bad reaction, which we believed changed his whole personality, was on to his vaccinations came when he got his MMR ON 12/3/2010.  Patient had an extremely high fever that night, (106), which we brought down with advised Tylenol and Motrin alternated every four hours and wet cloths to cool him down.  He shook like seizures, screamed, started pooping his pants with watery poop that ended up last five years to date.  He started waving his hands, refusing to wear shoes or clothes, screamed and hit himself, could not look at me anymore and kept spinning in circles and banging his head.  He also started repeating odd things he would hear and lined up all kinds of bizzare objects.  He was not the same little boy anymore.  We knew he was seriously damaged since the day he took that shot.  We subsequently brought him back to his doctor to tell him what had happened to Patient.  He, Dr. said he suspected autism and sent us to a specialist.
Age: 1.26
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR
Symptoms: Yellow skin
Clinical narrative: This was the first time I had ever seen one of my children turn completely yellow. (I have had three sons prior to this who were at this time 20, 15 and 10 years old.) I was so freaked out I brought him back to the doctor who told me it must be something I was eating and that it couldn't have been his vaccines.  I told him what a difficult time my boy was having, the screaming, the lack of sleep--he told me to stop nursing him and give him Formula.  I did not.  I continued to nurse him and he regained his normal color after several months.  His second very bad reaction, which we believed changed his whole personality, was on to his vaccinations came when he got his MMR ON 12/3/2010.  Patient had an extremely high fever that night, (106), which we brought down with advised Tylenol and Motrin alternated every four hours and wet cloths to cool him down.  He shook like seizures, screamed, started pooping his pants with watery poop that ended up last five years to date.  He started waving his hands, refusing to wear shoes or clothes, screamed and hit himself, could not look at me anymore and kept spinning in circles and banging his head.  He also started repeating odd things he would hear and lined up all kinds of bizzare objects.  He was not the same little boy anymore.  We knew he was seriously damaged since the day he took that shot.  We subsequently brought him back to his doctor to tell him what had happened to Patient.  He, Dr. said he suspected autism and sent us to a specialist.
Age: 52.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Rash erythematous, Rash pruritic
Clinical narrative: Tiny, red, itchy spots on body appeared 1 & 1/2 days after vaccine.  Soreness at injection site reported 1 & 1/2 days after vaccine.
Age: 14.0
Sex: F
Vaccine: FLUC3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Patient under the age of 18 given Flucelvax indicated for age 18 and up.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Confusional state, Dizziness, Headache, Paraesthesia, Pyrexia
Clinical narrative: Extreme dizziness, vomiting, slight headache at lower back of the neck, low fever, some mental confusion, some tingling in extremities, blurred vision.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Vision blurred, Vomiting
Clinical narrative: Extreme dizziness, vomiting, slight headache at lower back of the neck, low fever, some mental confusion, some tingling in extremities, blurred vision.
Age: 61.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site swelling, Injection site warmth, Local reaction, Pain in extremity, Peripheral swelling
Clinical narrative: Patient called pharmacy and said her arm was swollen and sore. She said she felt fine and that it was just sore. I explained that she may want to use Ibuprofen and ice to see if that may give her relief. She came to pharmacy the next day and upon further inspection it appeared that the patient had suffered a local injection site reaction. The area on her arm was warm and swollen. This occurred at 6:21PM on 9/26/2015. I recommended that she continue with Ibuprofen and ice the area and that I would follow up with her in the morning. The patient was afebrile and not complaining of anything other than her arm being tender and sore. I explained that if she was not feeling better that she may need to go to emergency department. She said that she felt fine and that she would be all right.
Age: 61.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Tenderness
Clinical narrative: Patient called pharmacy and said her arm was swollen and sore. She said she felt fine and that it was just sore. I explained that she may want to use Ibuprofen and ice to see if that may give her relief. She came to pharmacy the next day and upon further inspection it appeared that the patient had suffered a local injection site reaction. The area on her arm was warm and swollen. This occurred at 6:21PM on 9/26/2015. I recommended that she continue with Ibuprofen and ice the area and that I would follow up with her in the morning. The patient was afebrile and not complaining of anything other than her arm being tender and sore. I explained that if she was not feeling better that she may need to go to emergency department. She said that she felt fine and that she would be all right.
Age: 39.0
Sex: F
Vaccine: FLU4, PPV, TDAP
Symptoms: Mobility decreased, Pain in extremity, Pyrexia
Clinical narrative: ARM SO SORE, COULD HARDLY LIFT IT BY EVENING TIME, AND LOW GRADE FEVER OF 99.5.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Discomfort, Feeling hot
Clinical narrative: Patient said felt warm all over, and her body felt heavy.  We monitored her blood pressure and pulse.  Then we gave her 25mg of diphenhydramine liquid, and continue to monitor her, her blood pressure, and her pulse for the next 50 to 60 minutes.